8 research outputs found
Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
publication date: 2008-04-17; filing date: 2007-10-19The current invention concerns novel antiangiogenic peptides which correspond to about 10 to about 150 consecutive amino acids of N-terminal sequences of human growth hormones, human placental lactogen, human growth hormone variant hGH-V, and prolactin, and their use in inhibiting angiogenesis and in the diagnosis of diseases of human pregnancy involving abnormalities of placental vascularization